{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:06:58Z","timestamp":1763665618222,"version":"3.41.0"},"reference-count":9,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,6,15]]},"DOI":"10.2169\/internalmedicine.4144-24","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T22:11:46Z","timestamp":1729203106000},"page":"1849-1857","source":"Crossref","is-referenced-by-count":3,"title":["Delayed Trastuzumab-induced Cardiotoxicity Leading to Severe Left Ventricular Dysfunction"],"prefix":"10.2169","volume":"64","author":[{"given":"Ikuo","family":"Misumi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ueki Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kumamoto Brest and Gastrointestinal Surgical Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kumamoto Shinto General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kumamoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Dekita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kumamoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Usuku","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bouwer NI, Steenbruggen TG, Rosmalen J, et al. Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring? Breast Cancer Res Treat 186: 851-862, 2021.","DOI":"10.1007\/s10549-020-06039-w"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Albakri A. Drugs-related cardiomyopathy: a systematic review and pooled analysis of pathophysiology, diagnosis and clinical management. Intern Med Care 3: 1-19, 2019.","DOI":"10.15761\/IMC.1000129"},{"key":"3","unstructured":"3. Lyon AR, Lopez-Fernandez T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43: 4229-4361, 2022."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24: 1710-1718, 2003.","DOI":"10.1016\/S0195-668X(03)00476-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yang H, Wright L, Negishi T, Negishi K, Liu J, Marwick TH. Research to practice: assessment of left ventricular global longitudinal strain for surveillance of cancer chemotherapeutic-related cardiac dysfunction. JACC Cardiovasc Imaging 11: 1196-1201, 2018.","DOI":"10.1016\/j.jcmg.2018.07.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dent SF, Morse A, Burnette S, Guha A, Moore H. Cardiovascular toxicity of novel HER2-targeted therapies in the treatment of breast cancer. Curr Oncol Rep 23: 128, 2021.","DOI":"10.1007\/s11912-021-01114-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bouwer NI, Steenbruggen TG, van Rosmalen J, et al. Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring? Breast Cancer Res Treat 186: 851-862, 2021.","DOI":"10.1007\/s10549-020-06039-w"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ito M, Horimoto Y, Sasaki R, Miyazaki S, Orihata G, Saito M. Cardiotoxicity after additional administration of pertuzumab following long-term trastuzumab: report of 2 cases. Case Rep Oncol 14: 62-66, 2021.","DOI":"10.1159\/000513002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sardesai S, Sukumar J, Kassem M, et al. Clinical impact of interruption in adjuvant trastuzumab therapy in patients with operable HER-2 positive breast cancer. Cardiooncology 6: 26, 2020.","DOI":"10.1186\/s40959-020-00081-9"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/12\/64_4144-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:00:16Z","timestamp":1750478416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/12\/64_4144-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4144-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,6,15]]},"article-number":"4144-24"}}